ERC-AG-LS6
ERC-AG-LS6
Programme: H2020
69 projects · €151,631,416 total EU contribution (project-level) · 60 participating organizations · 19 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€151,631,416
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (14)
- UK (8)
- CH (6)
- France (6)
- Italy (5)
- Spain (4)
- Netherlands (3)
- IL (2)
- AT (1)
- BE (1)
- CA (1)
- DK (1)
- EL (1)
- FI (1)
- HR (1)
- IE (1)
- NO (1)
- PT (1)
- ZA (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- IP5 projects · FR
- CNRS3 projects · FR
- INSERM3 projects · FR
- UOXF3 projects · UK
- GERMAN CANCER RESEARCH CENTER2 projects · DE
- ETH Zürich2 projects · CH
- IRB2 projects · CH
- HUMANITAS MIRASOLE SPA2 projects · IT
- INSTITUT CURIE FONDATION2 projects · FR
- MPG2 projects · DE
- MRC2 projects · UK
- NKI AVL2 projects · NL
Projects
Page 5 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Recognition of bacteria by NK cells BACNK · 320473 | FP7 | €2,499,800 | €2,499,800 | Details |
Regulation and Function of CARD9 / BCL10 / MALT1 Signalosomes in Innate Immunity and Inflammation CBM-INNATE · 322865 | FP7 | €2,440,200 | €2,440,200 | Details |
Novel properties of antigen receptors and instruments to modulate lymphoid function in physiological and pathological conditions NOVARIPP · 334763 | FP7 | €2,491,827 | €2,491,827 | Details |
Dissecting the human T cell response to pathogens, allergens, and self-antigens PREDICT · 323183 | FP7 | €2,495,200 | €2,495,200 | Details |
Genetic and environmental factors that control inflammation-driven colon cancer INCA · 341009 | FP7 | €2,484,620 | €2,484,620 | Details |
Innate signaling networks in B cell antibody production: new targets for vaccine development B-INNATE · 294561 | FP7 | €2,214,035 | €2,214,035 | Details |
Cyclic-di-GMP: New Concepts in Second Messenger Signaling and Bacterial Biofilm Formation SECMESSBIOFILM · 249780 | FP7 | €1,998,000 | €1,998,000 | Details |
Primary immunodeficiency diseases as models for the study of the immune system PIDIMMUN · 249816 | FP7 | €1,719,600 | €1,719,600 | Details |
FIC-Mediated Post-Translational Modifications at thePathogen-Host Interface: Elucidating Structure, Function and Role in Infection FICModFun · 340330 | FP7 | €1,699,858 | €1,699,858 | Details |
Monoallelic Gene Expression in Malaria Parasites: A Key Mechanisms in the Pathogen's Survival Strategy PLASMOESCAPE · 250320 | FP7 | €1,815,480 | €1,815,480 | Details |